48,466
edits
Difference between revisions of "Ovarian tumours"
Jump to navigation
Jump to search
m
→Risk of malignancy index
| Line 12: | Line 12: | ||
Elements & points (RIM 2):<ref name=ukguide>URL: [http://www.sign.ac.uk/guidelines/fulltext/75/section3.html http://www.sign.ac.uk/guidelines/fulltext/75/section3.html]. Accessed on: 16 September 2011.</ref> | Elements & points (RIM 2):<ref name=ukguide>URL: [http://www.sign.ac.uk/guidelines/fulltext/75/section3.html http://www.sign.ac.uk/guidelines/fulltext/75/section3.html]. Accessed on: 16 September 2011.</ref> | ||
#Ultrasound features. | #Ultrasound features. | ||
#*Significant findings: multilocular cyst, solid component, bilateral lesions, ascites, suspected intra-abdominal metastases (one finding=1 point, two or more findings=4 points). | #*Significant findings: multilocular cyst, solid component, bilateral lesions, ascites, suspected intra-abdominal [[metastases]] (one finding=1 point, two or more findings=4 points). | ||
#Menopause/pre-menopause status (menopausal=4 points, pre-menopausal=1 point). | #Menopause/pre-menopause status (menopausal=4 points, pre-menopausal=1 point). | ||
#CA-125 (blood test) in ''U/ml''. | #CA-125 (blood test) in ''U/ml''. | ||